Evidence map›Paper›PMID 40579020›Full record

ArticleIn vivo (Athens, Greece)

Do Breast Cancer Patients With Chemotherapy-induced Peripheral Neuropathy Have an Increased Risk of Radiation Dermatitis?

Dirk Rades, Martin Ballegaard

Abstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dirk RadesDepartment of Radiation Oncology, University of Lübeck, Lübeck, Germany; dirk.rades@uksh.de.
Martin BallegaardDepartment of Neurology, Zealand University Hospital, Roskilde, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimPatients with breast cancer scheduled for irradiation may present with peripheral neuropathy (PNP) caused by preceding taxane-based chemotherapy. Chemotherapy-related toxicity was suggested to be associated with a lower individual DNA repair capacity. A similar association was described for radiation-related toxicity. We investigated whether patients with taxane-induced PNP have an increased risk of radiation dermatitis. PATIENTS AND

methodsIn a retrospective cohort of 129 patients irradiated for breast cancer following taxane-based chemotherapy, PNP plus 14 characteristics were evaluated for associations with grade ≥2 radiation dermatitis.

resultsNo, mild, and moderate to severe PNP were associated with grade ≥2 dermatitis rates of 22.2%, 27.7%, and 37.8% (

conclusionA significant association between severity of PNP and grade ≥2 radiation dermatitis was not found, although grade ≥2 dermatitis occurred more frequently in patients with moderate to severe PNP.

Indexed as

Antineoplastic AgentsBreast NeoplasmsPeripheral Nervous System DiseasesRadiodermatitisAdultAgedAntineoplastic Combined Chemotherapy ProtocolsFemaleHumansMiddle AgedRetrospective StudiesRisk FactorsTaxoidsAntineoplastic AgentsTaxoidsBreast cancerirradiationperipheral neuropathyradiation dermatitistaxane-based chemotherapy

Identifiers

PMID40579020
PMCPMC12223629

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.